Skip to content
Recall Observatory FDA recall evidence

Device product

RANDOX Total Bilirubin.

Z-0501-2024

October 11, 2023

Class II

Product summary

Firm
Randox Laboratories Ltd.
Event
Event 93387
Status
Ongoing
Classification
Class II
Quantity
1644 units
Official record key
device-enforcement:Z-0501-2024

Official wording

Reason: Randox has had reports of elevated patient results using Plasma (lithium heparin) samples with Total Bilirubin reagent (TBil) Vanadate Oxidation Method.

Code information: Catalog No. BR8377, BR9766, & BR4061; GTIN: 05055273214772, 05055273208337, & 05055273214765; All Batches.

Distribution pattern: US Nationwide distribution in the states of AR, GA, NC, TN, & PR.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Randox has had reports of elevated patient results using Plasma (lithium heparin) samples with Total Bilirubin reagent (TBil) Vanadate Oxidation Method.

Field note

Send feedback

We'll only use this to respond to your feedback.